Gpt Healthcare Limited · NSE:GPTHEALTH

Gpt Healthcare — Q1 FY26 Earnings Presentation

29 slides from Gpt Healthcare's earnings presentation, Aug 6, 2025

  1. Slide 1: Stock exchange submission letter for Investor Presentation

    GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2025-26 August 6, 2025 The Department of Corporate Services Nationa

  2. Slide 2: GPT Healthcare Limited Investor Presentation – Q1 FY26

    GPT Healthcare Limited Investor Presentation – Q1 FY26 N S E : G P T H E A LT H | B S E : 5 4 4 1 3 1

  3. Slide 3: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur

  4. Slide 4: Table of Content

    Table of Content 1 2 3 4 Q1 FY26 Company Business Annual Performance Overview Highlights Financials 3

  5. Slide 5: Q1 FY26 Performance

    Q1 FY26 Performance \ = ao \«& LS " ¥ . \

  6. Slide 6: GPT Healthcare – Key regional corporate healthcare companies in Eastern India

    GPT Healthcare – Key regional corporate healthcare companies in Eastern India ✓ Strategically located in Densely Populated Micro Markets of Kolkata, Howrah, Agartala and Raipur ✓ Established Right-Sized, Full-Service Hospitals according to each sub-region, aids High Return on Capital ✓ The EBITDA fo

  7. Slide 7: Financial Highlights – Q1 FY26

    Financial Highlights – Q1 FY26 Net Profit: Rs 7.7 Cr 41% Tax: Rs 3.4 Cr 18% 17% EBITDA : Depreciation: Rs 6.2 Cr 33% Rs 18.9 Cr Finance Costs Rs 1.6 Cr 8% Total Income : Rs 108.7 Cr Medicines and Consumables: 23% 100 % Rs 20.7 Cr __% Employee Benefit Costs : Rs 20.4 Cr 22% Total Expenses: Rs 89.8 Cr

  8. Slide 8: Road Ahead

    Road Ahead Margins Maintain long term Return on Equity and Return on Capital Employed close to 25% Size Return Ratios Target to become a 1,000 Maintain long term Return on Equity and bed facility in the next Return on Capital 2 years with a focus on Employed close to 25% Tier I and Tier II cities in

  9. Slide 9: Hospital wise Performance – Q1 FY26

    Hospital wise Performance – Q1 FY26 Bed Capacity Revenue Bed Occupancy Rate ARPOB Year of Commissing (No. of Beds) (Rs in Crore) (%) (Rs Per day) 59.9% Salt Lake Hospital 2000 85 19.6 42,313 51.5% Agartala Hospital 2011 205 34.4 35,633 59.8% Dum Dum Hospital 2013 155 35.9 42,684 38.8% Howrah Hospita

  10. Slide 10: Profit & Loss Highlights – Q1 FY26

    Profit & Loss Highlights – Q1 FY26 Particulars (Rs Cr) Q1 FY26 Q1FY25 YoY Q4FY25 QoQ FY25 FY24 YoY Revenue from operations 107.1 97.8 9.5% 101.4 5.6% 407.1 400.2 1.7% Other Income 1.6 2.2 -30.4% 1.6 0.0% 8.5 5.3 60.4% Total Income 108.7 100.1 8.6% 103.0 5.5% 415.6 405.5 2.5% Cost of materials consum

  11. Slide 11: Key Growth Initiatives

    Key Growth Initiatives Continued Investment in Infrastructure New Hospital ✓ Installed cutting-edge robotic surgical Existing Hospitals technology in Salt Lake and Howrah Hospital ✓ Setting up hospitals on Asset-light basis with 500+ robotic surgeries successfully where investment in land and buildi

  12. Slide 12: Company Overview

    Company Overview

  13. Slide 13: Salt Lake Hospital (Year 2000)

    Salt Lake Hospital (Year 2000) Total 85 Beds, including 17 Beds across ICUs and HDUs along with 3 OTs The Department of Minimal Access Surgery is accredited by National Board of Examinations for training of post-graduate surgeons under the Fellowship of National Board in Minimal Access Surgery Award

  14. Slide 14: Agartala Hospital (Year 2011)

    Agartala Hospital (Year 2011) Total 205 Beds, including 66 Beds across ICUs along with 8 OTs & 1 catheterization laboratory The only NABH accredited hospital in Agartala and one among 11 valid accredited hospitals in North-East India as of October 2023. Also accredited by NABL Received the ‘Excellen

  15. Slide 15: Dum Dum Hospital (Year 2013)

    Dum Dum Hospital (Year 2013) Total 155 Beds, including 53 Beds across ICUs and HDUs along with 4 OTs & 1 catheterization laboratory NABH accredited and NABL accredited for complying with ISO 15189:2012 standards in the field of medical testing Recognized by the CII for Excellence in Nursing for thei

  16. Slide 16: Howrah Hospital (Year 2019)

    Howrah Hospital (Year 2019) Total 116 Beds, including 43 Beds across ICUs and HDUs along with 3 OTs & 1 catheterization laboratory Near Howrah station, the site holds strong potential with no hospital within 5 km Recognized by the CII for Excellence in Nursing for their efforts, commitment and contr

  17. Slide 17: New ILS Raipur Hospital – (May 2025)

    New ILS Raipur Hospital – (May 2025) Quaternary Care, 158 beds including ICUs & HDUs, 5 OTs, and Oncology facilities. At Pachpedi Naka, Raipur, the facility will serve patients across Raipur, Bilaspur, Durg, and Bhilai. Equipped with 3 Tesla MRI, Cardiac Cath Lab and Dual Source CT Scan for precise

  18. Slide 18: Business Highlights

    Business Highlights

  19. Slide 19: Focused on High Return on Capital – Factors that lead to it

    Focused on High Return on Capital – Factors that lead to it Strategic Location Disciplined Approach Brand Strength Right Sized, towards Costs demonstrated through of the Hospitals Full Service Payor Mix Being in populous neighbourhoods Operating multispecialty, mid sized Strategic measures towards V

  20. Slide 20: Professional and experienced leadership – Board of Directors

    Professional and experienced leadership – Board of Directors Dwarika Prasad Tantia Dr. Om Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Wholetime Director Managing Director Whole-time Director Non - Executive Director Non - Executive Director C C M M M M • Founding member of I

  21. Slide 21: Annual Performance

    A} A. Annual Performance

  22. Slide 22: Key Financial Metrics

    Key Financial Metrics Revenue from Operations (Rs Cr) EBITDA & EBIDTA Margin PAT & PAT Margin 23.0% 21.8% 23.0% 22.1% 400 407 12.2% 11.9% 12.0% 361 17.4% 50 337 42 10.6% 39 48 7.1% 79 80 93 92 19 8 107 FY22 FY23 FY24 FY25 Q1 FY26 FY22 FY23 FY24 FY25 Q1 FY26 FY22 FY23 FY24 FY25 Q1 FY26 EBITDA (Rs Cr)

  23. Slide 23: Key Operational Metrics

    Key Operational Metrics No. of Beds & Occupancy Rate (%) Average Length of Stay (ALOS) Revenue Average from Revenue Operations Per (Rs(ARPOB) Occupied Bed Cr) 37,180 38,913 56.4% 58.9% 58.9% 53.1% 719 32,947 29,253 29,671 42.0% 4.80 556 561 561 561 4.22 3.95 3.54 3.48 FY22 FY23 FY24 FY25 Q1 FY26 FY2

  24. Slide 24: Diverse Revenue Mix Across Top 10 Specialties

    Diverse Revenue Mix Across Top 10 Specialties Internal Medicine & Diabetology Nepharology General Surgery Critical Care Paediactics Gastroenterology Gynaecology and obstetrics Interventional cardiology Orthopaedics and Joint Replacement Neurosciences Others 10% 12% 11% 3% 19% 2% 18% 19% 5% 6% 7% 8%

  25. Slide 25: Annual Profit & Loss

    Annual Profit & Loss Particulars (Rs Cr) FY24 FY25 Revenue from operations 400.2 407.1 Other Income 5.3 8.5 Total Income 405.5 415.6 Cost of materials consumed 83.0 78.8 Employee benefits expense 68.9 73 Other expenses 160.5 171.9 EBITDA 93.1 91.9 EBITDA Margin 23.0% 22.1% Depreciation and amortisat

  26. Slide 26: Balance Sheet

    Balance Sheet Assets (Rs Cr) Mar-24 Mar-25 Liabilities (Rs Cr) Mar-24 Mar-25 PPE 201.1 202.6 Share Capital 82.1 82.1 Other Equity 136.4 165.8 Other Non-Current Asset 45.1 46.3 Total Equity 218.5 247.9 Investments 19.2 56.5 Borrowings 3.6 5.5 Non-Current Assets 265.4 305.4 Lease Liabilities 15.3 17.2

  27. Slide 27: Cash Flow Statement

    Cash Flow Statement Particulars (in Cr) Mar-24 Mar-25 Cash Flow from Operating Activities Profit before Tax 68.0 69.3 Adjustment from Non-Operating Items Operating Profit before Working Capital 90.0 88.1 (Increase)/decrease in Inventories 0.8 -0.7 (Increase)/decrease in Trade Receivables -5.4 0.6 (I

  28. Slide 28: Stock Information

    Stock Information Share Price Movement Shareholding Pattern (as on June 30, 2025) 250 Public Promoters 20.2% DII 65.6% 200 Interim Dividend of Re.1/- 9.3% FII 5.0% 150 Price in Rs 100 Promoters FII DII Public Script Related Information (as on 04-August-2025) 50 BSE/NSE Code 544131 | GPTHEALTH CMP (R

  29. Slide 29: Thank You

    Thank ou GPT Healthcare Limited CIN No.: L70101WB1989PLC047402 ghl.cosec@gptgroup.co.in For more details : www.ilshospitals.com

GPT Healthcare — Q1 FY26 Earnings Presentation on 6ix